$ Value
$0
Shares
195,000
Price
$0
Filed
Feb 18
Insider
Name
MICHEL GERARD J
Title
CHIEF EXECUTIVE OFFICER
CIK
0001235644
Roles
Transaction Details
Transaction Date
2026-02-17
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
195,000
Footnotes
The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.
Filing Info
MICHEL GERARD J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | DCTH | ▲ | $100K ★ |
| 2026-02-17 | DCTH | A | $0 |
| 2026-02-17 | DCTH | A | $0 |
| 2026-01-13 | BBNX | A | $0 |
| 2025-11-11 | DCTH | ▲ | $98K |
Other Insiders at DCTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER
|
$100K | — | 2026-03-02 |
|
Pennell Sandra
Chief Financial Officer
|
$50K | — | 2026-03-06 |
|
Vukovic Vojo
CHIEF MEDICAL OFFICER
|
— | — | 2026-02-17 |
|
Muir Kevin
GM INTERVENTIONAL ONCOLOGY
|
— | — | 2026-02-17 |
|
Hoffman David L.
GEN'L COUNSEL, CCO & SECY
|
— | — | 2026-02-17 |
|
Rook Martha S.
CHIEF OPERATING OFFICER
|
— | — | 2026-02-17 |